title: Selective androgen receptor modulators--prospects for emerging therapy in osteoporosis?
authors.affiliation: Pfizer Global Research and Development, Groton, CT 06340, USA.
authors.forename: H Z
authors.initials: HZ
authors.lastname: Ke
authors.forename: X N
authors.initials: XN
authors.lastname: Wang
authors.forename: J
authors.initials: J
authors.lastname: O'Malley
authors.forename: B
authors.initials: B
authors.lastname: Lefker
authors.forename: D D
authors.initials: DD
authors.lastname: Thompson
mesh_terms: D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000188:drug therapy*; D011944:Receptors, Androgen / Q000187:drug effects; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use*
chemical_list: D011944:Receptors, Androgen; D020845:Selective Estrogen Receptor Modulators